China Meheco Co Ltd

SHG:600056 China Medical Distribution
Market Cap
$2.16 Billion
CN¥15.84 Billion CNY
Market Cap Rank
#7248 Global
#1220 in China
Share Price
CN¥10.59
Change (1 day)
+0.19%
52-Week Range
CN¥9.58 - CN¥12.05
All Time High
CN¥28.08
Categories
Companies in China Medical Distribution
About

China Meheco Group Co., Ltd. engages in the manufacture, marketing, and trade of pharmaceuticals and medical devices in China and internationally. The company is involved in the planting and sale of Chinese medicinal materials, as well as the provision of related technical and warehousing services. Its drug products cover therapeutic fields, such as anti-infection, cardiovascular, hormones and en… Read more

China Meheco Co Ltd (600056) - Net Assets

Latest net assets as of September 2025: CN¥14.29 Billion CNY

Based on the latest financial reports, China Meheco Co Ltd (600056) has net assets worth CN¥14.29 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥36.99 Billion) and total liabilities (CN¥22.70 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥14.29 Billion
% of Total Assets 38.64%
Annual Growth Rate 18.47%
5-Year Change 15.49%
10-Year Change 133.66%
Growth Volatility 43.39

China Meheco Co Ltd - Net Assets Trend (1994–2024)

This chart illustrates how China Meheco Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for China Meheco Co Ltd (1994–2024)

The table below shows the annual net assets of China Meheco Co Ltd from 1994 to 2024.

Year Net Assets Change
2024-12-31 CN¥14.11 Billion +1.61%
2023-12-31 CN¥13.89 Billion +5.42%
2022-12-31 CN¥13.17 Billion +5.31%
2021-12-31 CN¥12.51 Billion +2.38%
2020-12-31 CN¥12.22 Billion +10.97%
2019-12-31 CN¥11.01 Billion +8.62%
2018-12-31 CN¥10.14 Billion +14.10%
2017-12-31 CN¥8.88 Billion +15.63%
2016-12-31 CN¥7.68 Billion +27.23%
2015-12-31 CN¥6.04 Billion +10.17%
2014-12-31 CN¥5.48 Billion +41.53%
2013-12-31 CN¥3.87 Billion +68.14%
2012-12-31 CN¥2.30 Billion +20.44%
2011-12-31 CN¥1.91 Billion +18.86%
2010-12-31 CN¥1.61 Billion -0.52%
2009-12-31 CN¥1.62 Billion +37.32%
2008-12-31 CN¥1.18 Billion -23.63%
2007-12-31 CN¥1.54 Billion +115.26%
2006-12-31 CN¥716.57 Million -6.54%
2005-12-31 CN¥766.70 Million +15.89%
2004-12-31 CN¥661.58 Million +5.64%
2003-12-31 CN¥626.26 Million +7.35%
2002-12-31 CN¥583.37 Million +6.05%
2001-12-31 CN¥550.11 Million +7.31%
2000-12-31 CN¥512.65 Million +34.78%
1999-12-31 CN¥380.35 Million -0.45%
1998-12-31 CN¥382.07 Million -1.07%
1997-12-31 CN¥386.19 Million +215.72%
1996-12-31 CN¥122.32 Million +19.59%
1995-12-31 CN¥102.28 Million +17.23%
1994-12-31 CN¥87.25 Million --

Equity Component Analysis

This analysis shows how different components contribute to China Meheco Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1486559.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥7.63 Billion 64.52%
Common Stock CN¥1.50 Billion 12.65%
Other Components CN¥2.70 Billion 22.83%
Total Equity CN¥11.82 Billion 100.00%

China Meheco Co Ltd Competitors by Market Cap

The table below lists competitors of China Meheco Co Ltd ranked by their market capitalization.

Company Market Cap
OSG Corporation
F:OSG
 		$1.02 Billion
Bangchak Corporation Public Company Limited
BK:BCP-R
 		$1.02 Billion
Pilot Corporation
OTCGREY:POGHF
 		$1.02 Billion
Micro Tech Nanjing Co Ltd
SHG:688029
 		$1.02 Billion
Tompkins Financial Corporation
NYSE MKT:TMP
 		$1.02 Billion
Juventus Football Club S.p.A
PINK:JVTSF
 		$1.02 Billion
Goosehead Insurance Inc
NASDAQ:GSHD
 		$1.02 Billion
Air France-KLM SA
PINK:AFRAF
 		$1.02 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in China Meheco Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 11,560,548,147 to 11,820,516,000, a change of 259,967,853 (2.2%).
  • Net income of 535,467,695 contributed positively to equity growth.
  • Dividend payments of 510,909,564 reduced retained earnings.
  • Share repurchases of 22,896,880 reduced equity.
  • Other factors increased equity by 258,306,602.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥535.47 Million +4.53%
Dividends Paid CN¥510.91 Million -4.32%
Share Repurchases CN¥22.90 Million -0.19%
Other Changes CN¥258.31 Million +2.19%
Total Change CN¥- 2.25%

Book Value vs Market Value Analysis

This analysis compares China Meheco Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.34x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 75.48x to 1.34x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1994-12-31 CN¥0.14 CN¥10.59 x
1995-12-31 CN¥0.16 CN¥10.59 x
1996-12-31 CN¥0.20 CN¥10.59 x
1997-12-31 CN¥0.62 CN¥10.59 x
1998-12-31 CN¥0.61 CN¥10.59 x
1999-12-31 CN¥0.61 CN¥10.59 x
2000-12-31 CN¥0.82 CN¥10.59 x
2001-12-31 CN¥0.88 CN¥10.59 x
2002-12-31 CN¥0.94 CN¥10.59 x
2003-12-31 CN¥1.00 CN¥10.59 x
2004-12-31 CN¥0.98 CN¥10.59 x
2005-12-31 CN¥1.10 CN¥10.59 x
2006-12-31 CN¥0.72 CN¥10.59 x
2007-12-31 CN¥1.64 CN¥10.59 x
2008-12-31 CN¥1.22 CN¥10.59 x
2009-12-31 CN¥1.68 CN¥10.59 x
2010-12-31 CN¥1.67 CN¥10.59 x
2011-12-31 CN¥1.91 CN¥10.59 x
2012-12-31 CN¥1.56 CN¥10.59 x
2013-12-31 CN¥2.68 CN¥10.59 x
2014-12-31 CN¥3.60 CN¥10.59 x
2015-12-31 CN¥3.81 CN¥10.59 x
2016-12-31 CN¥4.79 CN¥10.59 x
2017-12-31 CN¥7.26 CN¥10.59 x
2018-12-31 CN¥5.65 CN¥10.59 x
2019-12-31 CN¥8.42 CN¥10.59 x
2020-12-31 CN¥9.36 CN¥10.59 x
2021-12-31 CN¥6.86 CN¥10.59 x
2022-12-31 CN¥7.23 CN¥10.59 x
2023-12-31 CN¥7.73 CN¥10.59 x
2024-12-31 CN¥7.90 CN¥10.59 x

Capital Efficiency Dashboard

This dashboard shows how efficiently China Meheco Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.53%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 1.57%
  • • Asset Turnover: 0.97x
  • • Equity Multiplier: 2.98x
  • Recent ROE (4.53%) is below the historical average (14.27%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1994 40.64% 2.73% 4.18x 3.56x CN¥26.73 Million
1995 43.06% 3.56% 4.09x 2.96x CN¥33.82 Million
1996 38.37% 2.06% 6.08x 3.06x CN¥34.70 Million
1997 16.02% 3.16% 2.59x 1.96x CN¥23.23 Million
1998 11.69% 2.56% 2.26x 2.02x CN¥6.44 Million
1999 8.32% 2.15% 1.62x 2.39x CN¥-6.40 Million
2000 6.29% 2.30% 1.25x 2.19x CN¥-19.01 Million
2001 8.91% 1.97% 2.06x 2.19x CN¥-5.98 Million
2002 7.75% 1.96% 2.30x 1.72x CN¥-13.09 Million
2003 6.79% 1.59% 2.90x 1.47x CN¥-20.05 Million
2004 1.07% 0.30% 2.24x 1.59x CN¥-54.48 Million
2005 10.62% 3.76% 1.15x 2.45x CN¥4.25 Million
2006 11.51% 2.68% 1.56x 2.75x CN¥9.48 Million
2007 16.38% 9.49% 0.91x 1.90x CN¥91.52 Million
2008 15.39% 5.29% 1.26x 2.31x CN¥57.10 Million
2009 12.91% 3.95% 0.88x 3.73x CN¥42.68 Million
2010 13.40% 3.11% 1.20x 3.60x CN¥49.41 Million
2011 16.18% 3.70% 1.18x 3.71x CN¥102.71 Million
2012 20.80% 3.07% 1.66x 4.09x CN¥216.03 Million
2013 14.10% 3.27% 1.16x 3.72x CN¥141.07 Million
2014 11.06% 3.08% 1.26x 2.85x CN¥52.58 Million
2015 11.38% 2.99% 1.27x 2.99x CN¥74.42 Million
2016 13.81% 3.66% 1.33x 2.84x CN¥261.80 Million
2017 16.93% 4.33% 1.43x 2.73x CN¥537.46 Million
2018 18.27% 4.98% 1.22x 3.00x CN¥699.35 Million
2019 10.91% 2.78% 1.18x 3.32x CN¥81.86 Million
2020 13.10% 3.33% 1.18x 3.32x CN¥310.12 Million
2021 6.31% 1.79% 1.16x 3.03x CN¥-378.74 Million
2022 6.80% 1.96% 1.05x 3.32x CN¥-345.98 Million
2023 9.07% 2.70% 1.04x 3.24x CN¥-108.02 Million
2024 4.53% 1.57% 0.97x 2.98x CN¥-646.58 Million

Industry Comparison

This section compares China Meheco Co Ltd's net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $3,241,551,628
  • Average return on equity (ROE) among peers: 8.48%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
China Meheco Co Ltd (600056) CN¥14.29 Billion 40.64% 1.59x $1.02 Billion
C.Q. Pharmaceutical Holding Co Ltd (000950) $2.07 Billion -17.42% 2.29x $534.66 Million
Shenzhen Glory Medical Co Ltd (002551) $2.78 Billion 3.52% 0.48x $272.16 Million
Shandong Realcan Pharmaceutical Co Ltd (002589) $5.64 Billion 0.36% 1.96x $431.85 Million
Qingdao Baheal Medical INC. (301015) $2.64 Billion 26.95% 1.01x $461.20 Million
Liaoning Cheng Da Co Ltd (600739) $111.50 Million 23.69% 2.83x $1.40 Billion
Jointown Pharmaceutical Group Co Ltd (600998) $8.09 Billion 6.93% 1.98x $1.61 Billion
Guangxi Liuzhou Pharm Co Ltd (603368) $1.36 Billion 15.31% 2.16x $667.23 Million